Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients.

BMC Neuroscience
Dietrich E LorkeDavid T Yew

Abstract

It has been hypothesized that alterations of the serotonergic system contribute to neuropsychiatric symptoms in Alzheimer disease (AD). Cellular expressions of the two serotonergic receptors 5-HT2A and 5-HT6 have therefore been determined by immunohistochemistry in the prefrontal cortex of patients with AD (n=6) and normal age-matched controls (n = 7). In normal aging patients, 5-HT2A label was mainly observed in large pyramidal cells, but to a lesser extent also in small pyramidal cells and in stellate cells of cortical layers II-VI. In AD, a similar distribution was observed, but density of positive cells was significantly reduced by 33%. In aging control patients, the 5-HT6 receptor was expressed by pyramidal cells and occasional stellate cells, not only of layers II-V, but also of layer I, where a distinct label was observed in neurons and surrounding fibers. 5-HT6 receptor expression in AD patients had the same pattern, but was significantly decreased by 40%. Our results indicate that a decline in neurons expressing 5-HT2A, but also 5-HT6 receptors may play a role in the etiopathology of neuropsychiatric symptoms in AD.

References

Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jan 1, 1990·Journal of Neural Transmission. Parkinson's Disease and Dementia Section·D DewarJ McCulloch
Jan 1, 1987·Journal of Neurochemistry·A M PalmerD M Bowen
Feb 1, 1989·British Journal of Industrial Medicine·A SeldénO Axelson
Dec 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D M BowenE Murphy
Apr 1, 1988·Journal of the Neurological Sciences·A W ProcterD M Bowen
Feb 1, 1989·Archives of Neurology·D L Sparks
Aug 1, 1988·Annals of Neurology·R M ZweigD L Price
Dec 1, 1984·Journal of Neurochemistry·A J CrossJ A Corsellis
Jul 1, 1984·Journal of Neuropathology and Experimental Neurology·C A Curcio, T Kemper
Feb 23, 1996·The Journal of Biological Chemistry·R M NitschR J Wurtman
Jan 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R L Jakab, P S Goldman-Rakic
May 8, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·C C MeltzerC F Reynolds
May 15, 1998·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·J L Cummings, C Back
Mar 10, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·P T FrancisG K Wilcock
Jun 24, 1999·The Journal of Comparative Neurology·V Cornea-HébertL Descarries
Aug 26, 1999·Neuropharmacology·N M Barnes, T Sharp
Dec 28, 1999·Journal of Neurology, Neurosurgery, and Psychiatry·T Babic
Feb 23, 2000·The Journal of Comparative Neurology·R L Jakab, P S Goldman-Rakic
Mar 17, 2000·Brain Research. Brain Research Reviews·G K Aghajanian, G J Marek
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·T A Branchek, T P Blackburn
Feb 24, 2001·The Journal of Neuropsychiatry and Clinical Neurosciences·K L LanctôtP Mazzotta
Dec 1, 2001·Journal of Neural Transmission·J ThomeM Rösler
Mar 1, 2002·The American Journal of Psychiatry·Ghanshyam N PandeyCarol A Tamminga
Jul 30, 2002·Progress in Brain Research·Victoria ArangoJ John Mann
Feb 4, 2003·The American Journal of Psychiatry·David L SultzerJeffrey L Cummings
Apr 23, 2003·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Clive HolmesSimon Lovestone
Sep 16, 2003·International Journal of Geriatric Psychiatry·Ezio Giacobini
Oct 23, 2003·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·M Garcia-AllozaM J Ramírez
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJunji Ichikawa

❮ Previous
Next ❯

Citations

Nov 28, 2012·Molecular Psychiatry·J H LedoS T Ferreira
Apr 12, 2016·Frontiers in Pharmacology·Lieven D DeclercqGuy Bormans
Aug 31, 2016·Proceedings of the National Academy of Sciences of the United States of America·Weipang ChangJianguo G Gu
Mar 5, 2018·Psychopharmacology·Anand M BokareYogendra Nayak
Jun 1, 2018·Expert Opinion on Investigational Drugs·Rita KhouryGeorge T Grossberg
Apr 28, 2009·Journal of Neuroscience Research·Ellen S MitchellJohn F Neumaier
Sep 18, 2009·Medicinal Research Reviews·Murat OzGeorge A Petroianu
Jan 21, 2011·Nature Reviews. Neuroscience·Amantha Thathiah, Bart De Strooper
Apr 28, 2010·Expert Review of Neurotherapeutics·Joshua D Grill, Jeffrey L Cummings
Sep 3, 2011·Journal of Neurochemistry·Rolf Postina
Apr 13, 2007·Fukushima Journal of Medical Science·Masatake KuritaNorimichi Nakahata
Feb 4, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Lea T DryeUNKNOWN CitAD Research Group
Mar 28, 2017·Reviews in the Neurosciences·Alfredo Meneses
Dec 26, 2006·The Journal of Biological Chemistry·Hyung-Mun YunHyewhon Rhim
Dec 19, 2018·International Psychogeriatrics·Shinji MatsunagaHajime Takechi
Oct 21, 2017·Scientific Reports·Susanna C Larsson, Hugh S Markus
Dec 10, 2016·Frontiers in Neuroscience·Giuseppe Di GiovanniPhilippe De Deurwaerdère
Aug 9, 2020·Frontiers in Neuroscience·Georg A Petroianu, Dietrich E Lorke
Mar 26, 2019·Journal of Alzheimer's Disease : JAD·Abhishek WadhawanTeodor T Postolache
Apr 10, 2010·International Journal of Immunopathology and Pharmacology·D E LorkeD T Yew
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hanish Singh Jayasingh ChellammalNarsimha Reddy Yellu
Apr 5, 2019·Neuroscience Letters·Saikat ChakrabortyHongxin Dong
Jan 27, 2017·Translational Neuroscience·Dubravka Švob ŠtracDorotea Mück-Šeler
Mar 6, 2015·ACS Chemical Neuroscience·Guadalupe MengodRoser Cortés
Jul 7, 2012·Progress in Neurobiology·José Julio RodríguezAlexei Verkhratsky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.